Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03272139 · ClinicalTrials.gov registry record · Phase 4
Interscalene Block Versus Superior Trunk Block
A Phase 4 study, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- Phase 4
- Development phase
- 126
- Enrollment target
NCT03272139 is a Phase 4 study that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 126 participants.
The verdict
NCT03272139, a Phase 4 study, has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 126 participants
- Enrollment target
Study Summary
Sparing the phrenic nerve by administering ultrasound-guided low volume superior trunk block (STB) and interscalene block (ISB) for arthroscopic shoulder surgery (labral repair, stabilization, rotator cuff repair).
Interventions
- DRUG Bupivacaine
- DEVICE Ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2017-09-28 |
| Est. Completion | 2019-07-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03272139
The ClinicalTrials.gov registry entry for NCT03272139 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bupivacaine is the first listed.
NCT03272139 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03272139 about?
NCT03272139 is a clinical study titled "Interscalene Block Versus Superior Trunk Block". Sparing the phrenic nerve by administering ultrasound-guided low volume superior trunk block (STB) and interscalene block (ISB) for arthroscopic shoulder surgery (labral repair, stabilization, rotator cuff repair).
What is the current status of trial NCT03272139?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 126 participants. The study started on 2017-09-28. Estimated completion is 2019-07-09.
What interventions are being tested in trial NCT03272139?
The interventions under investigation include: Bupivacaine (DRUG), Ultrasound (DEVICE).
Who is sponsoring clinical trial NCT03272139?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.